Does Mounjaro Give You Headaches? What the Evidence Shows

What the trial data and NHS guidance say about Mounjaro and headaches

The clearest evidence base for Mounjaro's side-effect profile comes from the SURMOUNT-1 phase 3 trial, published in the New England Journal of Medicine. Headache was among the adverse events recorded across all tirzepatide dose arms. It sits in the same category as the more frequently reported gastrointestinal effects (nausea, vomiting, constipation) but tends to be milder for most participants.

The NHS tirzepatide patient information lists headache under common side effects, meaning it affects somewhere between 1 in 10 and 1 in 100 people. That's a meaningful number, but it also means the majority of people on Mounjaro do not report it. Framing matters here: common in clinical-trial language does not mean inevitable.

Timing is also telling. Most reports cluster around starting treatment and after each dose step upward. The body's internal regulation of appetite, blood sugar and gut motility shifts with each change, and the nervous system can register that as a headache. Understanding why Mounjaro causes headaches biologically helps frame these episodes as part of adaptation rather than a signal something is wrong.

For a fuller picture of how headaches sit within the broader side-effect profile, including what triggers them, how long they tend to last, and when to seek advice, our dedicated guide to headaches on Mounjaro covers the topic in detail alongside the complete Mounjaro side-effects overview, which spans the full spectrum from GI effects to injection-site reactions.

Dehydration: the most likely culprit, and what to do about it

Tirzepatide slows the movement of food through the gut. That's part of how it works, but it also means nausea, and nausea means many people eat and drink less than usual in the first few days after a new pen or a dose increase. Less fluid in means a higher risk of a dehydration headache. It's a straightforward chain, and it's the most common reason headaches appear during the early weeks.

The practical response is equally straightforward: prioritise fluids, even when appetite is suppressed. Water, diluted squash, clear broths, small amounts, often. If nausea makes it hard to keep much down, sipping slowly throughout the day tends to be more effective than drinking large amounts at once. Caffeine withdrawal can compound things too: if reduced appetite means skipping the morning coffee, that alone can trigger a dull, persistent headache that has nothing to do with tirzepatide directly.

Some people find that other GI effects like burping accompany their early-treatment headaches, both tend to track the same dose-adjustment window. The good news is that both usually improve as the weeks pass. Headaches that appear only in the first week or two after starting or stepping up, then fade, are almost always part of this adjustment pattern.

When a headache on Mounjaro needs medical attention

Most headaches during tirzepatide treatment are mild tension-type episodes that respond to adequate hydration, rest and standard over-the-counter pain relief where appropriate. But some headaches warrant prompt contact with a clinician, and it's worth knowing the difference.

Get medical help quickly if you experience a headache that is sudden and severe, feels unlike any headache you have had before, or comes with visual disturbances, confusion, weakness on one side, difficulty speaking, or a stiff neck. These are not typical Mounjaro side effects and need urgent assessment independent of your weight-loss treatment.

Also contact your prescriber if you develop severe, persistent stomach pain that spreads toward your back, with or without vomiting. This is the pattern the MHRA highlighted in its January 2026 Drug Safety Update on acute pancreatitis and GLP-1 medicines, a rare but serious effect that requires prompt evaluation. You can report any suspected side effects, including headaches you're concerned about, directly through the MHRA's Yellow Card scheme. It's open to patients, carers and healthcare professionals alike.

The question of whether Mounjaro can give you a headache is well answered by the evidence. Whether it will, and how your individual pattern unfolds, is something to work through with a prescriber who knows your full history. Our prescribers discuss side effects and suitability as part of every consultation, before any prescription is written.

Headaches after you start, and across the dose schedule

Mounjaro treatment begins at 2.5 mg, a dose designed to let your system settle before therapeutic doses begin. Many people find any headaches are most noticeable at that starting point, and then again briefly at each step up (5 mg, 7.5 mg, and so on). Knowing this in advance makes the pattern easier to manage.

If you've been on Mounjaro for some time and headaches have started after a dose increase, they are almost certainly part of the same adaptation process, not a sign of a new problem. Give it a week or two, keep fluids up, and track the pattern. If they are not improving or are intensifying, that's the moment to contact your prescriber rather than waiting for the next scheduled review.

People transferring from another GLP-1 medicine sometimes ask whether Mounjaro causes more headaches than alternatives, a fair question, and one our clinical team addresses during the consultation. For a broader look at what to expect on this treatment, the Mounjaro treatment overview walks through the mechanism, the schedule and the evidence in full.

Once clinically approved, treatment is dispatched the same day and arrives in plain, unbranded packaging with DPD, the tracking notification lands on your phone, so there's no guessing when to be in. The pen itself is straightforward to use, but your prescriber and the Patient Information Leaflet cover technique in detail.